Dr. Matthew Potthoff, PhD, an Assistant Professor in the Department of Pharmacology, has been awarded a Carver Medical Research Initiative Grant.  The project, titled “Targeting FGF21 Production as a Therapeutic for Obesity and Metabolic Syndrome,” is focused on understanding the mechanisms regulating FGF21 production.  The goal of this research is to identify mechanisms to increase endogenous FGF21 expression as a treatment for metabolic disease.